AAO 2020: Comparing outcomes of xen gel stents in glaucoma practice

Conference|AAO

Davinder Grover, MD, MPH, speaks on the highlights of his presentation regarding outcomes of a 12-year study comparing ab externo vs ab interno xen gel stents in tertiary glaucoma practice.


During AAO 2020, Davinder Grover, MD, MPH, glaucoma specialist, Glaucoma Associates of Texas speaks on the highlights of his presentation regarding outcomes of a 12-year study comparing ab externo vs ab interno xen gel stents in tertiary glaucoma practice.

See more AAO coverage here

Related Videos
TENAYA, LUCERNE year 2 data reveals promising results for faricimab
How to diagnose geographic atrophy earlier
World Sight Day 2022: Eye care professionals share what global vision means to them
Related Content

Study: Cones in retinal degeneration, believed to be dormant, may retain visual function

March 28th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

COPHy 2023: Weighing the merits of offering teprotumumab for all patients with thyroid eye disease

March 25th 2023

What to expect from virtual AAO 2020

November 5th 2020

COPHy 2023 sets stage for evidence-based debates and discussions

March 15th 2023

UF Health researchers’ gene therapy for retina disorder shows promise in early testing

March 14th 2023

Study: Cones in retinal degeneration, believed to be dormant, may retain visual function

March 28th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

COPHy 2023: Weighing the merits of offering teprotumumab for all patients with thyroid eye disease

March 25th 2023

What to expect from virtual AAO 2020

November 5th 2020

COPHy 2023 sets stage for evidence-based debates and discussions

March 15th 2023

UF Health researchers’ gene therapy for retina disorder shows promise in early testing

March 14th 2023

Study: Cones in retinal degeneration, believed to be dormant, may retain visual function

March 28th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

COPHy 2023: Weighing the merits of offering teprotumumab for all patients with thyroid eye disease

March 25th 2023

What to expect from virtual AAO 2020

November 5th 2020

COPHy 2023 sets stage for evidence-based debates and discussions

March 15th 2023

UF Health researchers’ gene therapy for retina disorder shows promise in early testing

March 14th 2023
© 2023 MJH Life Sciences

All rights reserved.